Copyright
©The Author(s) 2017.
World J Clin Cases. Aug 16, 2017; 5(8): 324-332
Published online Aug 16, 2017. doi: 10.12998/wjcc.v5.i8.324
Published online Aug 16, 2017. doi: 10.12998/wjcc.v5.i8.324
Table 1 The most common sites of infection and mortality rates in sepsis
| Site of infection | Mortality (%) |
| Blood stream infection | 34.2 |
| Respiratory | 22 |
| Genitourinary | 8.2 |
| Wound and soft tissue infection | 10.55 |
| Abdomen | 10.25 |
| CNS | 17.4 |
| Device related | 9.5 |
| Endocarditis | 25.95 |
| Others | 7.05 |
Table 2 Resistance mechanisms of carbapenemase producing Enterobacteriaceae
| Class | Genetic mutation | Clavulanic acid inhibition |
| Class A | Chromosomal encoded (NmcA, Sme, IMI-1, SFC-1) | Partially inhibited |
| Plasmid encoded (IMI-2, GES, KPC) | ||
| Class B | Metallo-β-lactamase (IMP, VIM and NDM-1, SIM, GIM, SPM) | Resistant to clavulanic acid |
| Class D | Plasmid encoded oxa-48 | Resistant to clavulanic aci |
Table 3 Bed side risk score for carbapenem resistant Enterobacteriaceae
| Risk factor | Score (points) |
| History of chemotherapy in the last 3 mo | 19 |
| Invasive devices | 10 |
| Absence of peripheral vascular disease | 10 |
| Impairment of level of consciousness at the time of illness | 9 |
| Hospitalization for 3 or more days before development of BSI | 7 |
| Age < 65 years old | 6 |
- Citation: Alhashem F, Tiren-Verbeet NL, Alp E, Doganay M. Treatment of sepsis: What is the antibiotic choice in bacteremia due to carbapenem resistant Enterobacteriaceae? World J Clin Cases 2017; 5(8): 324-332
- URL: https://www.wjgnet.com/2307-8960/full/v5/i8/324.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v5.i8.324
